| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 8 | +75.00% | -2.49% | -0.28% | -2.21% | -1.57% | — |
| 14d | 8 | +75.00% | -3.70% | +0.01% | -3.71% | -4.79% | — |
| 30d | 8 | +75.00% | -4.25% | -0.67% | -6.06% | -6.49% | — |
| 60d | 8 | +50.00% | -5.95% | -3.15% | -2.79% | -7.20% | — |
| 90d | 8(1 pending) | +57.14% | -12.48% | +1.76% | -14.24% | -7.50% | — |
| 180d | 8(4 pending) | +50.00% | +12.34% | +0.74% | +11.60% | -27.95% | — |
| 1y | 8(5 pending) | +0.00% | +112.14% | +12.91% | +99.22% | +74.42% | — |
| 2y | 8(8 pending) | — | — | — | — | — | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| SPRO SPERO THERAPEUTICS, INC. | SALE See Remarks | 25,240 | $2.51 | $63.4K | 986,851 | May 4, 2026 | Feb 9, 2026 ↗ | View → |
| SPRO SPERO THERAPEUTICS, INC. | SALE See Remarks | 50,816 | $2.36 | $119.9K | 1,012,091 | Feb 6, 2026 | Feb 9, 2026 ↗ | View → |
| SPRO SPERO THERAPEUTICS, INC. | SALE See Remarks | 37,101 | $2.36 | $87.6K | 1,062,907 | Feb 6, 2026 | Feb 9, 2026 ↗ | View → |
| SPRO SPERO THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 249,000 | — | — | 1,118,450 | Feb 2, 2026 | Feb 4, 2026 ↗ | View → |
| SPRO SPERO THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 498,000 | — | — | 498,000 | Feb 2, 2026 | Feb 4, 2026 ↗ | View → |
| SPRO SPERO THERAPEUTICS, INC. | SALE See Remarks | 18,442 | $2.20 | $40.6K | 1,100,008 | Feb 2, 2026 | Feb 4, 2026 ↗ | View → |
| SPRO SPERO THERAPEUTICS, INC. | SALE See Remarks | 40,270 | $2.37 | $95.4K | 869,450 | Nov 7, 2025 | Nov 12, 2025 ↗ | View → |
| SPRO SPERO THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 185,000 | — | — | 909,720 | May 2, 2025 | May 6, 2025 ↗ | View → |
| SPRO SPERO THERAPEUTICS, INC. | SALE CFO & CBO | 20,689 | $0.78 | $16.1K | 724,720 | Feb 5, 2025 | Feb 5, 2025 ↗ | View → |
| SPRO SPERO THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 100,000 | — | — | 745,409 | Feb 3, 2025 | Feb 5, 2025 ↗ | View → |
| SPRO SPERO THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 266,139 | — | — | 645,409 | Feb 3, 2025 | Feb 5, 2025 ↗ | View → |
| SPRO SPERO THERAPEUTICS, INC. | SALE CFO & CBO | 17,245 | $1.30 | $22.4K | 379,270 | Nov 8, 2024 | Nov 12, 2024 ↗ | View → |
| SPRO SPERO THERAPEUTICS, INC. | SALE CFO & CBO | 23,351 | $1.31 | $30.6K | 396,515 | Nov 7, 2024 | Nov 12, 2024 ↗ | View → |
| SPRO SPERO THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 119,866 | — | — | 419,866 | Feb 1, 2024 | Feb 5, 2024 ↗ | View → |
| SPRO SPERO THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 300,000 | — | — | 300,000 | Nov 13, 2023 | Nov 15, 2023 ↗ | View → |
| FULC FULCRUM THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 160,000 | — | — | 160,000 | Feb 9, 2023 | Feb 13, 2023 ↗ | View → |
| FULC FULCRUM THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 200,000 | — | — | 200,000 | Jan 3, 2022 | Jan 10, 2022 ↗ | View → |